Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00028509 · ClinicalTrials.gov registry record

Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201

A clinical trial, sponsored by Children's Oncology Group.

Completed
Registry status
66
Enrollment target

NCT00028509 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 66 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00028509 has completed, sponsored by Children's Oncology Group.

COMPLETED
Registry status
66 participants
Enrollment target

Study Summary

RATIONALE: Assessing the effects of methotrexate on brain function in children may improve the ability to plan treatment and decrease side effects. PURPOSE: Clinical trial to compare brain function of children who have been previously treated with methotrexate.

Interventions

  • PROCEDURE management of therapy complications

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2002-07

Sponsor

Children's Oncology Group

342 total trials

What the Registry Record Tells You About NCT00028509

The ClinicalTrials.gov registry entry for NCT00028509 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which management of therapy complications is the first listed.

NCT00028509 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00028509 about?

NCT00028509 is a clinical study titled "Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201". RATIONALE: Assessing the effects of methotrexate on brain function in children may improve the ability to plan treatment and decrease side effects. PURPOSE: Clinical trial to compare brain function of children who have been previously treated with methotrexate.

What is the current status of trial NCT00028509?

This trial is currently completed. The enrollment target is 66 participants. The study started on 2002-07.

What interventions are being tested in trial NCT00028509?

The interventions under investigation include: management of therapy complications (PROCEDURE).

Who is sponsoring clinical trial NCT00028509?

This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.